Related Experiment Video
Updated: Jul 6, 2026

07:41
Design and Implementation of a Bespoke Robotic Manipulator for Extra-corporeal Ultrasound
Published on: January 7, 2019
Design and simulation of a visual and haptic assisted biopsy (ViHAB) system
Sumit Tandon1, Venkat Devarajan, Edmond Richter
1Department of Electrical Engineering, University of Texas at Arlington, TX, USA.
Studies in Health Technology and Informatics
|April 9, 2008
Summary
This study introduces the visually guided, haptically assisted breast biopsy (ViHAB) system, enhancing cancer diagnosis with real-time 3D ultrasound imaging and haptic feedback for improved needle guidance.
Area of Science:
- Medical Imaging
- Surgical Simulation
- Biotechnology
Background:
- Core needle biopsy is crucial for diagnosing breast and prostate cancer.
- Current image-based guidance systems for biopsy lack real-time, 3D visualization or use ionizing radiation.
- Limitations include non-real-time imaging, 2D visualization, and ionizing radiation in existing methods.
Purpose of the Study:
- To develop a visually guided, haptically assisted breast biopsy (ViHAB) system.
- To integrate real-time 3D ultrasound (US) imaging with haptic guidance for biopsy procedures.
- To enhance radiologist's ability to identify suspicious tissues and guide needle placement accurately.
Main Methods:
- Development of the ViHAB simulator at the Virtual Environment Laboratory.
- Utilizing real-time 3D US imaging for visualization and tracking.
- Incorporating haptic feedback and a joystick for virtual needle manipulation.
Main Results:
- The ViHAB simulator can read and display 3D US images in near real-time.
- The system tracks micro-calcifications across image sequences.
- It provides integrated haptic and visual guidance for a virtual biopsy needle.
Conclusions:
- The ViHAB system offers a promising approach for real-time, 3D image-guided biopsy.
- Haptic and visual feedback can improve the precision of needle placement during biopsies.
- This technology has the potential to enhance the accuracy and safety of minimally invasive cancer diagnosis.

